卫生研究

参考文献

[1]SCHRADER M,SCHULZ-KNAPPE P.Peptidomics technologies for human body fluids[J].Trends Biotechnol,2001,19(10 Suppl):S55-S60.

[2]HU L,YE M,ZOU H.Recent advances in mass spectrometry-based peptidome analysis[J].Expert Rev Proteomics,2009,6(4):433-447.

[3]BARBOSA E B,VIDOTTO A,POLACHINI G M,et al.Proteomics:methodologies and applications to the study of human diseases[J].Rev Assoc Med Bras,2012,58(3):366-375.

[4]DIAMANDIS E P.Peptidomics for cancer diagnosis:present and future[J].J Proteome Res,2006,5(9):2079-2082.

[5]IVANOV V T,YATSKIN O N.Peptidomics:a logical sequel to proteomics[J].Expert Rev Proteomics,2005,2(4):463-473.

[6]BEYOGLU D,IDLE J R.Metabolomics and its potential in drug development[J].Biochem Pharmacol,2013,85(1):12-20.

[7]SOLOVIEV M,FINCH P.Peptidomics:bridging the gap between proteome and metabolome[J].Proteomics,2006,6(3):744-747.

[8]SCHULZ-KNAPPE P,SCHRADER M,ZUCHT H D.The peptidomics concept[J].Comb Chem High Throughput Screen,2005,8(8):697-704.

[9]SCHULTE I,TAMMEN H,SELLE H,et al.Peptides in body fluids and tissues as markers of disease[J].Expert Rev Mol Diagn,2005,5(2):145-157.

[10]TUCHOLSKA M,SCOZZARO S,WILLIAMS D,et al.Endogenous peptides from biophysical and biochemical fractionation of serum analyzed by matrix-assisted laser desorption/ionization and electrospray ionization hybrid quadrupole time-offlight[J].Anal Biochem,2007,370(2):228-245.

[11]ARISTOTELI L P,MOLLOY M P,BAKER M S.Evaluation of endogenous plasma peptide extraction methods for mass spectrometric biomarker discovery[J].J Proteome Res,2007,6(2):571-581.

[12]WILLIAMS D,ACKLOO S,ZHU P,et al.Precipitation and selective extraction of human serum endogenous peptides with analysis by quadrupole time-of-flight mass spectrometry reveals posttranslational modifications and low-abundance peptides[J].Anal Bioanal Chem,2010,396(3):1223-1247.

[13]HELLER M,MATTOU H,MENZEL C,et al.Trypsin catalyzed16O-to-18O exchange for comparative proteomics:tandem mass spectrometry comparison using MALDI-TOF,ESI-QTOF,and ESI-ion trap mass spectrometers[J].J Am Soc Mass Spectrom,2003,14(7):704-718.

[14]XIANG Y,KUROKAWA M S,KANKE M,et al.Peptidomics:identification of pathogenic and marker peptides[J].Methods Mol Biol,2010(615):259-271.

[15]LING X B,LAU K,KANEGAYE J T,et al.A diagnostic algorithm combining clinical and molecular data distinguishes Kawasaki disease from other febrile illnesses[J].BMC Med,2011(9):130.

[16]CASALEGNO-GARDUNO R,SCHMITT A,SCHMITT M.Clinical peptide vaccination trials for leukemia patients[J].Expert Rev Vaccines,2011,10(6):785-799.

[17]SRINIVAS P R,KRAMER B S,SRIVASTAVA S.Trends in biomarker research for cancer detection[J].Lancet Oncol,2001,2(11):698-704.

[18]LIANG S L,CHAN D W.Enzymes and related proteins as cancer biomarkers:a proteomic approach[J].Clin Chim Acta,2007,381(1):93-97.

[19]PETRICOIN E F,BELLUCO C,ARAUJO R P,et al.The blood peptidome:a higher dimension of information content for cancer biomarker discovery[J].Nat Rev Cancer,2006,6(12):961-967.

[20]ANTWI K,HOSTETTER G,DEMEURE M J,et al.Analysis of the plasma peptidome from pancreas cancer patients connects a peptide in plasma to overexpression of the parent protein in tumors[J].J Proteome Res,2009,8(10):4722-4731.

[21]COHEN M,YOSSEF R,EREZ T,et al.Serum apolipoproteins C-I and C-III are reduced in stomach cancer patients:results from MALDI-based peptidome and immuno-based clinical assays[J].PLoS One,2011,6(1):e14540.

[22]UEDA K,SAICHI N,TAKAMI S,et al.A comprehensive peptidome profiling technology for the identification of early detection biomarkers for lung adenocarcinoma[J].PLoS One,2011,6(4):e18567.

[23]FREDOLINI C,MEANI F,LUCHINI A,et al.Investigation of the ovarian and prostate cancer peptidome for candidate early detection markers using a novel nanoparticle biomarker capture technology[J].AAPS J,2010,12(4):504-518.

[24]FAN N J,GAO C F,ZHAO G,et al.Serum peptidome patterns of breast cancer based on magnetic bead separation and mass spectrometry analysis[J].Diagn Pathol,2012(7):45.

[25]YANG J,SONG Y C,SONG T S,et al.Identification of novel low molecular weight serum peptidome biomarkers for non-small cell lung cancer(NSCLC)[J].J Clin Lab Anal,2012,26(3):148-154.

[26]FAN N J,GAO C F,WANG X L,et al.Serum peptidome patterns of colorectal cancer based on magnetic bead separation and MALDI-TOF mass spectrometry analysis[J].J Biomed Biotechnol,2012,doi:10.1155/2012/985020.

[27]CABRAS T,PISANO E,MASTINU A,et al.Alterations of the salivary secretory peptidome profile in children affected by type 1 diabetes[J].Mol Cell Proteomics,2010,9(10):2099-2108.

[28]SIWY J,ZOJA C,KLEIN J,et al.Evaluation of the Zucker diabetic fatty(ZDF)rat as a model for human disease based on urinary peptidomic profiles[J].PLoS One,2012,7(12):e51334.

[29]ARAKI Y,NONAKA D,TAJIMA A,et al.Quantitative peptidomic analysis by a newly developed one-step direct transfer technology without depletion of major blood proteins:its potential utility for monitoring of pathophysiological status in pregnancy-induced hypertension[J].Proteomics,2011,11(13):2727-2737.

[30]HOLTTA M,ZETTERBERG H,MIRGORODSKAYA E,et al.Peptidome analysis of cerebrospinal fluid by LC-MALDI MS[J].PLoS One,2012,7(8):e42555.

[31]BLENNOW K,ZETTERBERG H.Cerebrospinal fluid biomarkers for Alzheimer's disease[J].J Alzheimer's Disease,2009,18(2):413-417.

[32]SHI M,BRADNER J,HANCOCK A M,et al.Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression[J].Ann Neurol,2011,69(3):570-580.

[33]CHEN C,XIAO D,ZHOU W,et al.Comparative peptidome analyses of the profiles of the peptides ranging from 1-10 kD in CSF samples pooled from probable sporadic CJD and non-CJD patients[J].Prion,2012,6(1):46-51.

[34]WIJTE D,MCDONNELL L A,BALOG C I,et al.A novel peptidomics approach to detect markers of Alzheimer's disease in cerebrospinal fluid[J].Methods,2012,56(4):500-507.

[35]MUIXI L,CONTRERAS V,COLLADO J A,et al.Unraveling features of the natural MHC class II peptidome of skin-migrated dendritic cells[J].Int Immunol,2012,24(1):59-69.

[36]ANTWI K,HANAVAN P D,MYERS C E,et al.Proteomic identification of an MHC-binding peptidome from pancreas and breast cancer cell lines[J].Mol Immunol,2009,46(15):2931-2937.

[37]DAI Y,HU C,WANG L,et al.Serum peptidome patterns of human systemic lupus erythematosus based on magnetic bead separation and MALDI-TOF mass spectrometry analysis[J].Scand J Rheumatol,2010,39(3):240-246.

[38]TERRACCIANO R,PREIANO M,PALLADINO G P,et al.Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for non-invasive biomarker discovery of chronic inflammatory lung diseases[J].Proteomics,2011,11(16):3402-3414.

[39]LING X B,LAU K,DESHPANDE C,et al.Urine peptidomic and targeted plasma protein analyses in the diagnosis and monitoring of systemic juvenile idiopathic arthritis[J].Clin Proteomics,2010,6(4):175-193.

[40]QUINTANA L F,CAMPISTOL J M,ALCOLEA M P,et al.Application of label-free quantitative peptidomics for the identification of urinary biomarkers of kidney chronic allograft dysfunction[J].Mol Cell Proteomics,2009,8(7):1658-1673.

[41]LIU H,LANG J,ZHOU Q,et al.Detection of endometriosis with the use of plasma protein profiling by surface-enhanced laser desorption/ionization timeof-flight mass spectrometry[J].Fertil Steril,2007,87(4):988-990.

[42]GOOD D M,ZURBIG P,ARGILES A,et al.Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease[J].Mol Cell Proteomics,2010,9(11):2424-2437.